Skip to main content
S.Biomedics Co., Ltd. logo

S.Biomedics Co., Ltd. — Investor Relations & Filings

Ticker · 304360 ISIN · KR7304360001 KO Professional, scientific and technical activities
Open in API
Filings indexed 138 across all filing types
Latest filing 2023-05-11 Interim / Quarterly Rep…
Country KR South Korea
Listing KO 304360

About S.Biomedics Co., Ltd.

https://www.sbiomedics.com/eng/

S.Biomedics Co., Ltd. is a company specializing in the research and development of cell therapies for regenerative medicine. Established in 2005, the company focuses on creating, manufacturing, and supplying stem cell-based therapeutic products. Its core activities involve leveraging data-driven biology to develop fundamental and safe treatments for various conditions, with a significant focus on neurodegenerative disorders such as Parkinson's disease. S.Biomedics is committed to advancing the field of stem cell therapy from initial research to clinical application.

Recent filings

Filing Released Lang Actions
분기보고서 (2023.03)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the company 'S.Biomedics Co., Ltd.' covering the period from January 1, 2023, to March 31, 2023. It contains detailed company information, business overview, financial data, and management discussions, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2023
2023-05-11 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a mandatory disclosure by company insiders (directors/major shareholders) regarding their shareholdings and changes therein. In the context of the provided categories, this falls under 'Director's Dealing' (DIRS), which covers reports of personal share transactions or ownership status by company directors and executives.
2023-05-11 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status of (주)바이넥스 in (주)에스바이오메딕스 following the latter's KOSDAQ listing. This type of filing is specifically categorized as a Major Shareholding Notification (MRQ) in the provided schema.
2023-05-10 Korean
주식등의대량보유상황보고서(약식)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a regulatory filing required under the Capital Markets Act in South Korea when an entity acquires a significant stake (typically 5% or more) in a listed company. This is a standard disclosure document for major shareholding notifications, often referred to as a '5% rule' filing. Based on the provided categories, this fits the 'Major Shareholding Notification' (MRQ) classification.
2023-05-10 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is specifically used to disclose insider shareholdings and changes in ownership by directors or major shareholders. In the provided taxonomy, this corresponds to 'Director's Dealing' (DIRS), which covers insider transactions and ownership reporting.
2023-05-09 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a standard regulatory disclosure for insider shareholdings, which falls under the 'Director's Dealing' category (DIRS) as it reports the ownership status and changes in shareholdings by a company executive (Kim Jong-wan).
2023-05-08 Korean

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.